Drugs / NC-758
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00056238 | Feb 2003 → ? | stroke disorder | Bellus Health Inc. - a GSK company | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NC-758 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00056238 ↗ |